This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Dalhousie University directory, so their courses may be missing. Find their university profile.
Latest papers
RSV Bivalent Prefusion F Protein Vaccine in Pregnancy and Protection Against RSV-Associated Illness in Infants: A Systematic Review and Meta-Analysis.
JAMA pediatrics · 2026 · senior author
Long-acting monoclonal antibodies and the evolving landscape of infant respiratory syncytial virus prevention.
Pediatric investigation · 2026
A controlled human infection model for symptomatic pertussis in North America using the pertactin-producing clinical isolate D420.
medRxiv : the preprint server for health sciences · 2026
Latest funding
- $1,686,824
Concurrent versus sequential administration of Tdap and RSV vaccines in pregnancy a noninferiority randomized observer blinded placebo controlled multicenter phase 4 trial
CIHR · 2026 · Nominated PI
- $2,023,426
Understanding the impact of early-life RSV infections on infant immunity and long-term health
CIHR · 2025 · Co-investigator
Canadian Immunization Research Network (CIRN) Renewal
CIHR · 2024 · Co-investigator
14 publications.
RSV Bivalent Prefusion F Protein Vaccine in Pregnancy and Protection Against RSV-Associated Illness in Infants: A Systematic Review and Meta-Analysis.
Batool R, Wang R, Obeid H, Kollmann TR, Langley JM, Lavoie PM, Abu-Raya B
Long-acting monoclonal antibodies and the evolving landscape of infant respiratory syncytial virus prevention.
Wang R, Abu-Raya B, Obeid H, Xie Z
A controlled human infection model for symptomatic pertussis in North America using the pertactin-producing clinical isolate D420.
ElSherif MS, Redden KL, Langley JM, Ye L, Blanchard W, Smith B, Wang J, Abu-Raya B, Filliter JH, Edwards KM, Creech CB, McNeil S, Hatchette TF, LeBlanc JJ, Hariri S, Pawloski L, Maniatis P, Fox LM, Whittle CA, Halperin SA
Case presentation of patients hospitalised with mpox (subclade Ib/2023sh) including children, adolescents, and adults in South Kivu, Democratic Republic of the Congo: an observational cohort study.
Flores Girón L, Sganzerla Martinez G, Daniel BN, Bisimwa AK, Pacific N, Martin GA, Kabwana JCA, Kumar A, Toloue Ostadgavahi A, Dutt M, Bénite KL, Damien MH, Gortázar C, Abu-Raya B, Kelvin AA, Prince KK, Kelvin DJ
HKU1 immune imprinting is associated with post-COVID symptoms after SARS-CoV-2 infection.
Majdoubi A, Michalski C, Watts AW, Dang X, Golzan SA, Abu-Raya B, Li S, Shew J, Reicherz F, Mâsse LC, Lavoie PM
Editorial: The immunological effects of respiratory viruses during pregnancy and breastfeeding.
Liong S, Choy KHC, Selemidis S, Abu-Raya B, De Rose DU
Correction: Riccò et al. Respiratory Syncytial Virus: A WAidid Consensus Document on New Preventive Options. Vaccines 2024, 12, 1317.
Riccò M, Abu-Raya B, Icardi G, Spoulou V, Greenberg D, Pecurariu OF, Hung IF, Osterhaus A, Sambri V, Esposito S
Co-administration of vaccines in pregnancy: unique challenges and knowledge gaps.
Abu-Raya B, Giles ML, Kollmann T
Avidity of pertussis toxin antibodies following vaccination with genetically versus chemically detoxified pertussis toxin-containing vaccines during pregnancy.
Abu-Raya B, Del Giudice G, van den Biggelaar AHJ, Tang Y, Bhat N, Pham HT, Wijagkanalan W
Safety and immunogenicity of an acellular pertussis vaccine containing genetically detoxified pertussis toxin administered to pregnant women living with and without HIV and their newborns (WoMANPOWER): a randomised controlled trial in Uganda.
Nakabembe E, Greenland M, Amaral K, Abu-Raya B, Amone A, Andrews N, Cantrell L, Lesne E, Gorringe A, Halkerston R, Mcstraw N, Dixon L, Hunter OF, Heath PT, Imede E, Kyohere M, Musoke P, Nakimuli A, Sekikubo M, Taylor S, Tusubira V, Sadarangani M, Le Doare K
Concurrent versus sequential administration of Tdap and RSV vaccines in pregnancy a noninferiority randomized observer blinded placebo controlled multicenter phase 4 trial
Principal investigators: Abu-Raya, Bahaa H
Keywords: Pertussis; Rsv; Vaccination In Pregnancy
Understanding the impact of early-life RSV infections on infant immunity and long-term health
Principal investigators: Lavoie, Pascal
Keywords: Asthma/Wheezing; B Cell/Antibody Immune Responses; Flow Cytometry; Human Cohort Study; Immune Development; Immunization; Infant; Respiratory Syncytial Virus; Rna-Sequencing; Seasonal Respiratory Viruses
Canadian Immunization Research Network (CIRN) Renewal
Principal investigators: Halperin, Scott A; Andrew, Melissa K; Bettinger, Julie A; Bolotin, Shelly; Brisson, Marc; Buchan, Sarah; Cowan, Juthaporn; Dubé, Eve; Greyson, Devon; Hatchette, Todd F; Heffernan, Jane M; Kwong, Jeffrey C; Langley, Joanne M; MacDonald, Shannon E; McNeil, Shelly A; Muller, Matthew P; Parsons Leigh, Jeanna J; Sadarangani, Manish; Top, Karina A
Keywords: Adverse Events Following Immunization; Immunogenicity; Population-Based Methodology; Rapid Response Research Capacity; Vaccine Coverage; Vaccine Effectiveness; Vaccine Hesitancy; Vaccine Modeling And Economic Analysis; Vaccine Safety; Vulnerable Populations
Open-label, phase 1/2, dose-escalation and dose-confirmation clinical trial to establish a Controlled Human Infection Model (CHIM) by determining and confirming the optimal, safe, and reproducible Influenza A:H3N2 dose administered intranasally to healthy adults 18-40 years of age that induces mild symptomatic infection and detection of Influenza A:H3N2 in nasal secretions by culture and/or PCR
Principal investigators: Halperin, Scott A; Ward, Brian J
Keywords: Challenge Study; Challenge Unit; Controlled Human Infection Model (Chim); Dose-Finding; Dose-Ranging; Healthy Adults; Influenza Virus; Pandemic Preparedness; Phase 1/2 Clinical Trial
Open-label, phase 1/2, dose-escalation and dose-confirmation clinical trial to establish a Controlled Human Infection Model (CHIM) by determining and confirming the optimal, safe, and reproducible Influenza A:H3N2 dose administered intranasally to healthy adults 18-40 years of age that induces mild symptomatic infection and detection of Influenza A:H3N2 in nasal secretions by culture and/or PCR
Principal investigators: Halperin, Scott A; Ward, Brian J
Keywords: Challenge Study; Challenge Unit; Controlled Human Infection Model (Chim); Dose-Finding; Dose-Ranging; Healthy Adults; Influenza Virus; Pandemic Preparedness; Phase 1/2 Clinical Trial
Development of functional antibody assays to assess the immunogenicity of pertussis-containing vaccine (Tdap) for HIV-infected and HIV-uninfected pregnant women and their newborns
Principal investigators: Sadarangani, Manish
Keywords: Antibody; Pertussis; Pregnancy; Vaccines
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Shelly McNeil and Manish Sadarangani: 2 shared papers
- Shelly McNeil and Jun Wang: 1 shared paper
- Shelly McNeil and Bahaa Abu-Raya: 1 shared paper
- Jun Wang and Bahaa Abu-Raya: 1 shared paper
- Manish Sadarangani and Bahaa Abu-Raya: 1 shared paper
- Department of Pediatrics
- Department of Microbiology & Immunology
Co-authors at Dalhousie University, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.